Cargando…
Profile of Linzagolix in the Management of Endometriosis, Including Design, Development and Potential Place in Therapy: A Narrative Review
Estrogens play a critical role in the pathogenesis of endometriosis and it is logical to assume that lowering estradiol levels with oral gonadotropin-releasing hormone (GnRH) antagonists may prove effective, especially in women who fail to respond to progestogens. Indeed, due to progesterone resista...
Autores principales: | Donnez, Jacques, Cacciottola, Luciana, Squifflet, Jean-Luc, Dolmans, Marie-Madeleine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922511/ https://www.ncbi.nlm.nih.gov/pubmed/36789095 http://dx.doi.org/10.2147/DDDT.S269976 |
Ejemplares similares
-
Can Endometriosis-Related Oxidative Stress Pave the Way for New Treatment Targets?
por: Cacciottola, Luciana, et al.
Publicado: (2021) -
Conservative Management of Uterine Fibroid-Related Heavy Menstrual Bleeding and Infertility: Time for a Deeper Mechanistic Understanding and an Individualized Approach
por: Dolmans, Marie-Madeleine, et al.
Publicado: (2021) -
Endometriosis: An Inflammatory Disease That Requires New Therapeutic Options
por: Donnez, Jacques, et al.
Publicado: (2022) -
Emerging Drug Targets for Endometriosis
por: Dolmans, Marie-Madeleine, et al.
Publicado: (2022) -
Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review
por: Donnez, Jacques, et al.
Publicado: (2021)